References |
1 |
THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS
|
2 |
Clinical pharmacokinetics of methyldopa
|
3 |
Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label
|
4 |
Sulfate and methyldopa metabolism: metabolite patterns and platelet phenol sulfotransferase activity. Clin Pharmacol Ther. 1985 Mar;37(3):308-15.
|
5 |
The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects
|
6 |
Platelet phenol sulfotransferase and erythrocyte catechol-O-methyltransferase activities: correlation with methyldopa metabolism. Clin Pharmacol Ther. 1984 Jan;35(1):55-63.
|
7 |
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004 Apr;26(2):137-44.
|
8 |
DrugBank(Pharmacology-Metabolism):Methyldopate Hydrochloride
|